Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2223

1.

The relationship between antecedent creatinine decreases and outcomes in patients undergoing hemodialysis.

Harada T, Sorimachi H, Obokata M, Sunaga H, Ishida H, Ito K, Ogawa T, Ando Y, Kurabayashi M, Negishi K.

Hemodial Int. 2019 Oct 21. doi: 10.1111/hdi.12794. [Epub ahead of print]

PMID:
31633866
2.

Needle-shaped amyloid deposition in rat mammary gland: evidence of a novel amyloid fibril protein.

Murakami T, Noguchi K, Hachiya N, Kametani F, Tasaki M, Nakaba S, Sassa Y, Yamashita T, Obayashi K, Ando Y, Hamamura M, Kanno T, Kawasako K.

Amyloid. 2019 Oct 15:1-11. doi: 10.1080/13506129.2019.1675623. [Epub ahead of print]

PMID:
31615282
3.

New Concept Air Conditioning System for the Operating Room to Minimize Patient Cooling and Surgeon Heating: A Historical Control Cohort Study.

Usuki H, Kitamura H, Ando Y, Suto H, Asano E, Ohshima M, Kishino T, Kumamoto K, Okano K, Suzuki Y.

World J Surg. 2019 Oct 10. doi: 10.1007/s00268-019-05203-8. [Epub ahead of print]

PMID:
31602521
4.

Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors.

Uemura J, Okano K, Oshima M, Suto H, Ando Y, Kumamoto K, Kadota K, Ichihara S, Kokudo Y, Maeba T, Nanno Y, Toyama H, Takada Y, Shimada M, Hanazaki K, Masaki T, Suzuki Y.

Ann Surg. 2019 Oct 9. doi: 10.1097/SLA.0000000000003624. [Epub ahead of print]

PMID:
31599805
5.

[How to Place Percutaneous Cardiopulmonary Support(PCPS)].

Ando Y, Tokunaga S.

Kyobu Geka. 2019 Sep;72(10):734-737. Japanese.

PMID:
31582686
6.

Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy.

Hayashi Y, Higashi T, Motoyama K, Jono H, Ando Y, Onodera R, Arima H.

Biol Pharm Bull. 2019;42(10):1679-1688. doi: 10.1248/bpb.b19-00278.

7.

Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis.

Yamashita T, Ueda M, Nomura T, Okazaki T, Okada M, Tsuda Y, Inoue Y, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Inomata Y, Hibi T, Ando Y.

Neurology. 2019 Oct 15;93(16):714-716. doi: 10.1212/WNL.0000000000008320. Epub 2019 Sep 27. No abstract available.

PMID:
31562191
8.

Lipid and fatty acid dynamics by maternal Pacific bluefin tuna.

Hiraoka Y, Okochi Y, Ohshimo S, Shimose T, Ashida H, Sato T, Ando Y.

PLoS One. 2019 Sep 25;14(9):e0222824. doi: 10.1371/journal.pone.0222824. eCollection 2019.

9.
10.

Characteristics of acquired transthyretin amyloidosis: A case series and review of the literature.

Misumi Y, Ueda M, Masuda T, Tsuda Y, Nomura T, Okada M, Inoue Y, Tasaki M, Obayashi K, Yamashita T, Ando Y.

Neurology. 2019 Oct 22;93(17):e1587-e1596. doi: 10.1212/WNL.0000000000008360. Epub 2019 Sep 11.

PMID:
31511348
11.

Associations between dietary vitamin intake, ABCA1 gene promoter DNA methylation, and lipid profiles in a Japanese population.

Fujii R, Yamada H, Munetsuna E, Yamazaki M, Ando Y, Mizuno G, Tsuboi Y, Ohashi K, Ishikawa H, Hagiwara C, Maeda K, Hashimoto S, Suzuki K.

Am J Clin Nutr. 2019 Aug 26. pii: nqz181. doi: 10.1093/ajcn/nqz181. [Epub ahead of print]

PMID:
31504085
12.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI EXPERT CONSENSUS RECOMMENDATIONS FOR MULTIMODALITY IMAGING IN CARDIAC AMYLOIDOSIS: PART 1 OF 2-EVIDENCE BASE AND STANDARDIZED METHODS OF IMAGING.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Card Fail. 2019 Aug 6. pii: S1071-9164(19)31397-1. doi: 10.1016/j.cardfail.2019.08.001. [Epub ahead of print] No abstract available.

PMID:
31473268
13.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Card Fail. 2019 Aug 29. pii: S1071-9164(19)31398-3. doi: 10.1016/j.cardfail.2019.08.002. [Epub ahead of print]

PMID:
31473267
14.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Nucl Cardiol. 2019 Aug 29. doi: 10.1007/s12350-019-01761-5. [Epub ahead of print]

PMID:
31468377
15.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Nucl Cardiol. 2019 Aug 29. doi: 10.1007/s12350-019-01760-6. [Epub ahead of print] No abstract available.

PMID:
31468376
16.

Author Correction: Fingolimod-induced decrease in heart rate may predict subsequent decreasing degree of lymphocytes.

Ikeda T, Kakuma T, Watari M, Ando Y.

Sci Rep. 2019 Aug 28;9(1):12662. doi: 10.1038/s41598-019-48630-2.

17.

Muscle pathology of hereditary motor and sensory neuropathy with proximal dominant involvement with TFG mutation.

Yamashita S, Kimura E, Zhang Z, Tawara N, Hara K, Yoshimura A, Takashima H, Ando Y.

Muscle Nerve. 2019 Aug 26. doi: 10.1002/mus.26683. [Epub ahead of print]

PMID:
31449671
18.

Significance of N-isopropyl-[123I] p-iodoamphetamine single-photon emission computed tomography in detection of responsible hypoperfusion in hemichorea.

Sehara Y, Otsuka H, Kaneko N, Ando Y, Sawada M.

J Clin Neurosci. 2019 Aug 22. pii: S0967-5868(19)30905-1. doi: 10.1016/j.jocn.2019.07.072. [Epub ahead of print]

PMID:
31447357
19.

Detection of bacteria in blood circulation in patients receiving cancer chemotherapy.

Ota A, Morita S, Matsuoka A, Shimokata T, Maeda O, Mitsuma A, Yagi T, Asahara T, Ando Y.

Int J Clin Oncol. 2019 Aug 12. doi: 10.1007/s10147-019-01521-y. [Epub ahead of print]

PMID:
31407169
20.

CYLD dysregulation in pathogenesis of sporadic inclusion body myositis.

Yamashita S, Matsuo Y, Tawara N, Hara K, Yamamoto M, Nishikami T, Kawakami K, Zhang X, Zhang Z, Doki T, Ando Y.

Sci Rep. 2019 Aug 12;9(1):11606. doi: 10.1038/s41598-019-48115-2.

21.

Stent Retriever-Assisted Continuous Aspiration for Distal Intracranial Vessel Embolectomy: The Distal Combined Technique.

Miura M, Shindo S, Nakajima M, Namitome S, Wada K, Nagao Y, Sugimura Y, Terasaki T, Ando Y.

World Neurosurg. 2019 Aug 2. pii: S1878-8750(19)32118-7. doi: 10.1016/j.wneu.2019.07.202. [Epub ahead of print]

PMID:
31382073
22.

Spatial Regulation of Mitochondrial Heterogeneity by Stromal Confinement in Micropatterned Tumor Models.

Begum HM, Ta HP, Zhou H, Ando Y, Kang D, Nemes K, Mariano CF, Hao J, Yu M, Shen K.

Sci Rep. 2019 Aug 1;9(1):11187. doi: 10.1038/s41598-019-47593-8.

23.

Recent progress of chemotherapy and biomarkers for gastroesophageal cancer.

Maeda O, Ando Y.

World J Gastrointest Oncol. 2019 Jul 15;11(7):518-526. doi: 10.4251/wjgo.v11.i7.518. Review.

24.

Analysis of Microstructure of Granules Prepared by Continuous Twin Screw Granulator Using X-Ray Micro-computed Tomography.

Matsui Y, Ando Y, Yamamoto K, Watano S.

Chem Pharm Bull (Tokyo). 2019;67(8):801-809. doi: 10.1248/cpb.c19-00076.

25.

Reader response: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.

Ueda M, Yamashita T, Misumi Y, Masuda T, Ando Y.

Neurology. 2019 Jul 30;93(5):228-229. doi: 10.1212/WNL.0000000000007870. No abstract available.

PMID:
31358673
26.

The current status of the Transthyretin Amyloidosis Outcomes Survey (THAOS) in Japan.

Sekijima Y, Mundayat R, Ishii T, Ando Y.

Amyloid. 2019;26(sup1):61-62. doi: 10.1080/13506129.2019.1583182. No abstract available.

PMID:
31343365
27.

Serum diacron-reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP) in patients with ATTR-PN.

Obayashi K, Masuda T, Tasaki M, Ando Y, Ueda M.

Amyloid. 2019;26(sup1):65. doi: 10.1080/13506129.2019.1583183. No abstract available.

PMID:
31343364
28.

Evaluation of myoelectrical activities of descending colon by electrointestinogram in patients with ATTRm amyloidosis.

Obayashi K, Masuda T, Tasaki M, Ando Y, Ueda M.

Amyloid. 2019;26(sup1):66. doi: 10.1080/13506129.2019.1583184. No abstract available.

PMID:
31343362
29.

Introduction.

Ando Y, Ueda M, Jono H.

Amyloid. 2019;26(sup1):1-3. doi: 10.1080/13506129.2019.1594184. No abstract available.

PMID:
31343350
30.

Histopathological and biochemical analyses of prostate corpora amylacea.

Kanenawa K, Ueda M, Isoguchi A, Nomura T, Tsuda Y, Masuda T, Misumi Y, Yamashita T, Ando Y.

Amyloid. 2019;26(sup1):160-161. doi: 10.1080/13506129.2019.1583189. No abstract available.

PMID:
31343347
31.

Class I small leucine-rich proteoglycans (SLRPs) colocalise with the Aβ2M amyloid deposits: implications for the roles of SLRP core proteins in the pathogenesis of dialysis-related amyloidosis.

Yamaguchi I, Kokubo Y, Yamashita T, Ueda M, Okoshi T, Matsumine A, Ando Y, Naiki H.

Amyloid. 2019;26(sup1):140-141. doi: 10.1080/13506129.2019.1582498. No abstract available.

PMID:
31343344
32.

Changes in nerve excitability indices in hereditary transthyretin amyloidosis.

Yamashita T, Ueda M, Misawa S, Inoue Y, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Kuwabara S, Ando Y.

Amyloid. 2019;26(sup1):9-10. doi: 10.1080/13506129.2019.1582480. No abstract available.

PMID:
31343340
33.

Nationwide survey of 199 patients with reactive amyloid a amyloidosis in Japan.

Okuda Y, Yamada T, Ueda M, Ando Y.

Amyloid. 2019;26(sup1):129. doi: 10.1080/13506129.2019.1583177. No abstract available.

PMID:
31343335
34.

Transthyretin amyloid-related cerebral angiitis after liver transplantation.

Yamashita T, Ohnishi K, Ueda M, Masuda T, Inoue Y, Misumi Y, Ueda A, Obayashi K, Takeya M, Ando Y.

Amyloid. 2019;26(sup1):11-12. doi: 10.1080/13506129.2019.1583179. No abstract available.

PMID:
31343330
35.

AL amyloidosis diagnosed using anti-IGLL5 antibody: a case report.

Hiroi T, Mushino T, Tanaka K, Furuya Y, Hori Y, Oiwa T, Kobata H, Yamashita Y, Hosoi H, Murata S, Nishikawa A, Tamura S, Takeuchi S, Nohgawa M, Yamashita T, Ando Y, Hata H, Sonoki T.

Amyloid. 2019;26(sup1):111-112. doi: 10.1080/13506129.2019.1585343. No abstract available.

PMID:
31343322
36.

Clinical and MRI characteristics and follow-up studies of insulin-derived amyloidosis.

Nagase T, Iwaya K, Zako T, Odaka T, Kogure K, Nemoto Y, Misumi Y, Noritake M, Ando Y, Katsura Y.

Amyloid. 2019;26(sup1):156-157. doi: 10.1080/13506129.2019.1582517. No abstract available.

PMID:
31343315
37.

Clinical potential of dual-energy cardiac CT in cardiac amyloidosis.

Oda S, Nakaura T, Utsunomiya D, Hirakawa K, Takashio S, Izumiya Y, Tsujita K, Kawano Y, Okuno Y, Hata H, Matsuoka M, Yamashita T, Ueda M, Ando Y, Yamashita Y.

Amyloid. 2019;26(sup1):91-92. doi: 10.1080/13506129.2019.1582021. No abstract available.

PMID:
31343298
38.

Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis.

Masuda T, Ueda M, Misumi Y, Nomura T, Inoue Y, Isoguchi A, Kanenawa K, Tasaki M, Yamashita T, Sonoda Y, Obayashi K, Ando Y.

Amyloid. 2019;26(sup1):79-80. doi: 10.1080/13506129.2019.1583198. No abstract available.

PMID:
31343297
39.

A novel transgenic mouse model expressing mutant TTR gene causing oculoleptomeningeal type of ATTRm amyloidosis.

Isoguchi A, Ueda M, Kanenawa K, Masuda T, Misumi Y, Yamashita T, Obayashi K, Ando Y.

Amyloid. 2019;26(sup1):69. doi: 10.1080/13506129.2019.1583190. No abstract available.

PMID:
31343295
40.

Correlation of heart rate variability analysis and MIBG myocardial scintigraphy in patients with Parkinson's disease.

Nakahara K, Nakane S, Ando Y.

Amyloid. 2019;26(sup1):146-147. doi: 10.1080/13506129.2019.1582505. No abstract available.

PMID:
31343292
41.

Patient profile with ATTR-FAP and evaluation of the safety and efficacy of tafamidis meglumine in Japan - interim analysis in post-marketing surveillance.

Ishii T, Sekijima Y, Ando Y.

Amyloid. 2019;26(sup1):45-46. doi: 10.1080/13506129.2019.1582508. No abstract available.

PMID:
31343289
42.

Comparison of clinical features in transient focal neurological episodes between hereditary transthyretin type and Aβ type cerebral amyloid angiopathy.

Nakajima M, Takeuchi Y, Nagao Y, Masuda T, Yamashita T, Yonehara T, Terasaki T, Ando Y.

Amyloid. 2019;26(sup1):81-82. doi: 10.1080/13506129.2019.1583199. No abstract available.

PMID:
31343286
43.

Effect of L-Leucine Therapy on Hematopoietic Function in Elderly Myelodysplastic Syndrome Patients.

Ito K, Hayashi T, Inaguma Y, Terazawa T, Ando M, Ando Y, Tsuge M, Kato A, Shimato A, Suzuki S, Kato S, Tomita A, Yamada S, Emi N.

Biol Pharm Bull. 2019 Oct 1;42(10):1651-1657. doi: 10.1248/bpb.b19-00184. Epub 2019 Jul 25.

44.

Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy.

Ochi Y, Kubo T, Nakashima Y, Baba Y, Hirota T, Yamasaki N, Yamashita T, Ueda M, Ando Y, Kitaoka H.

J Cardiol. 2019 Jul 16. pii: S0914-5087(19)30150-9. doi: 10.1016/j.jjcc.2019.05.011. [Epub ahead of print]

PMID:
31324572
45.

Maternal fructose-induced oxidative stress occurs via Tfam and Ucp5 epigenetic regulation in offspring hippocampi.

Yamada H, Munetsuna E, Yamazaki M, Mizuno G, Sadamoto N, Ando Y, Fujii R, Shiogama K, Ishikawa H, Suzuki K, Shimono Y, Ohashi K, Hashimoto S.

FASEB J. 2019 Oct;33(10):11431-11442. doi: 10.1096/fj.201901072R. Epub 2019 Jul 17.

PMID:
31314594
46.

Implication of Molecular Weight on Optical and Charge Transport Anisotropy in PQT-C12 Films Fabricated by Dynamic FTM.

Tripathi ASM, Sadakata S, Gupta RK, Nagamatsu S, Ando Y, Pandey SS.

ACS Appl Mater Interfaces. 2019 Aug 7;11(31):28088-28095. doi: 10.1021/acsami.9b06568. Epub 2019 Jul 29.

PMID:
31309839
47.

Ovarian abscess caused by Helicobacter cinaedi in a patient with endometriosis.

Sato H, Ogino A, Matsuzaka S, Asami Y, Kanbayashi S, Masuda M, Nakashima A, Yasuda M, Morishita H, Ando Y, Oida K, Taguchi N, Hirose M.

IDCases. 2019 Jun 25;17:e00578. doi: 10.1016/j.idcr.2019.e00578. eCollection 2019.

48.

Early palliative balloon pulmonary valvuloplasty in neonates and young infants with tetralogy of Fallot.

Muneuchi J, Watanabe M, Sugitani Y, Kawaguchi N, Matsuoka R, Ando Y, Ochiai Y.

Heart Vessels. 2019 Jul 13. doi: 10.1007/s00380-019-01468-0. [Epub ahead of print]

PMID:
31302722
49.

Alterations in gene expression and DNA methylation profiles in gastric cancer cells obtained from ascitic fluids collected before and after chemotherapy.

Maeda O, Matsuoka A, Furukawa K, Miyahara R, Hirooka Y, Ando Y.

Mol Clin Oncol. 2019 Jul;11(1):91-98. doi: 10.3892/mco.2019.1858. Epub 2019 May 10.

50.

Memantine, a Noncompetitive N-Methyl-D-Aspartate Receptor Antagonist, Attenuates Cerebral Amyloid Angiopathy by Increasing Insulin-Degrading Enzyme Expression.

Inoue Y, Ueda M, Masuda T, Misumi Y, Yamashita T, Ando Y.

Mol Neurobiol. 2019 Jul 6. doi: 10.1007/s12035-019-01678-7. [Epub ahead of print]

PMID:
31280448

Supplemental Content

Support Center